Intralipid Infusion and Migraine After Embryo Transfer

Adverse Effects of Intralipid

• The known adverse effects of intravenous lipid emulsions relate primarily to metabolic complications, such as hypertriglyceridemia and fat overload syndrome, rather than neurological symptoms, in patients receiving intralipid at embryo transfer 1, 2, 3

Timing Considerations

• Acute infusion reactions to lipid emulsions typically occur during or immediately after administration, not hours later, in women undergoing embryo transfer 1, 4
• Hypertriglyceridemia from lipid infusions peaks approximately 4 hours after initiation, but this metabolic effect does not manifest as migraine, in patients receiving intralipid 3, 4

Metabolic Monitoring

• Monitor triglyceride levels if multiple intralipid infusions are planned, though metabolic derangements do not typically present as isolated migraine, in patients with a history of hypertriglyceridemia 3, 4

Clinical Context

• The American Society for Reproductive Medicine and the European Society of Human Reproduction and Embryology may provide guidelines for the use of intralipid in IVF protocols, although the evidence for intralipid use in IVF is limited and based on small trials with moderate risk of bias, in women undergoing embryo transfer 5, 6, 7